Study of 15,000 patients proposes RSV vaccine to prevent deaths in the elderly

A study conducted at the Entre Douro e Vouga Local Health Unit analyzed 15,000 hospitalized patients and found that 18.3% of those infected with Respiratory Syncytial Virus (RSV) died, a higher mortality rate than for influenza. The lead researcher recommends that the SNS begin subsidizing the vaccine for those over 60, as the current cost of approximately 200 euros per dose makes it inaccessible to many seniors.